Role of Splenectomy in the Treatment of Myelodysplastic Syndromes With Peripheral Thrombocytopenia: A Report on Six Cases

Leukemia - United Kingdom
doi 10.1038/sj.leu.2402129
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Springer Science and Business Media LLC

Related search

Significance of Thrombocytopenia in Myelodysplastic Syndromes: Associations and Prognostic Implications

Clinical Lymphoma, Myeloma and Leukemia
Cancer ResearchOncologyHematology
2011English

Is There a Role for All-Trans Retinoic Acid in Combination With Recombinant Erythropoetin in Myelodysplastic Syndromes? A Report on 59 Cases

Leukemia
Cancer ResearchOncologyAnesthesiologyPain MedicineHematology
2009English

Altered Immunophenotypic Features of Peripheral Blood Platelets in Myelodysplastic Syndromes

Haematologica
Hematology
2012English

Management of Cytopenias During Treatment With Lenalidomide in Patients With Myelodysplastic Syndromes

The Open Leukemia Journal
2010English

Six (Or More) Drugs in Search of a Mechanism: DNA Methyltransferase and Histone Deacetylase Inhibitors in the Treatment of Myelodysplastic Syndromes

Journal of the National Comprehensive Cancer Network : JNCCN
MedicineOncology
2006English

Prognostic Role of TET2 Deficiency in Myelodysplastic Syndromes: A Meta-Analysis

Oncotarget
Oncology
2017English

The Myelodysplastic Syndromes

Emerging Cancer Therapeutics
2011English

A Rare Case of Myelodysplastic Syndrome With Refractory Thrombocytopenia

Hematology Reports
Hematology
2015English

The Myelodysplastic Syndromes

Oncologist
Cancer ResearchMedicineOncology
1997English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy